These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Leukopenia associated with aminoglutethimide therapy: a case report. Austerlitz J Cancer Treat Rep; 1982 Oct; 66(10):1879. PubMed ID: 7127328 [No Abstract] [Full Text] [Related]
25. Neutropenia induced by aminoglutethimide in breast cancer. Steinberg JL; Trudeau ME J R Soc Med; 1993 Aug; 86(8):480-1. PubMed ID: 8078051 [No Abstract] [Full Text] [Related]
26. Severe leukopenia induced by aminoglutethimide. Kampel LJ; Kurman MR Cancer Treat Rep; 1984 Oct; 68(10):1277-8. PubMed ID: 6525598 [No Abstract] [Full Text] [Related]
27. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer. Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526 [TBL] [Abstract][Full Text] [Related]
28. Aminoglutethimide in the management of advanced breast cancer. Smith IE; Coombes RC; Ford HT; Gazet JC; Harmer C; Jones M; McKinna JA; Powles TJ Eur J Cancer (1965); 1980; Suppl 1():99-101. PubMed ID: 7318876 [No Abstract] [Full Text] [Related]
29. Systemic lupus erythematosus induced by aminoglutethimide. McCraken M; Benson EA; Hickling P Br Med J; 1980 Nov; 281(6250):1254. PubMed ID: 7427657 [No Abstract] [Full Text] [Related]
30. Severe hyponatremia following simultaneous administration of aminoglutethimide and diuretics. Bork E; Hansen M Cancer Treat Rep; 1986 May; 70(5):689-90. PubMed ID: 3708624 [No Abstract] [Full Text] [Related]
31. [Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day]. Bonneterre J; Coppens H; Mauriac L; Rouesse J; Fargeot P; Metz R; Armand JP; Mathieu A; Tubiana M; Cappelaere P Acta Clin Belg Suppl; 1986; 11():41-8. PubMed ID: 3521171 [No Abstract] [Full Text] [Related]
32. Extended adjuvant therapy for breast cancer--how much is enough? Prowell TM; Stearns V J Natl Cancer Inst; 2007 Dec; 99(24):1825-7. PubMed ID: 18073372 [No Abstract] [Full Text] [Related]
33. Preliminary trial of aminoglutethimide in breast cancer. Griffiths CT; Hall TC; Saba Z; Barlow JJ; Nevinny HB Cancer; 1973 Jul; 32(1):31-7. PubMed ID: 4716782 [No Abstract] [Full Text] [Related]
35. Clinical studies with aminoglutethimide in advanced breast carcinoma. Harvey HA; Lipton A; Santen RJ Acta Clin Belg Suppl; 1986; 11():29-40. PubMed ID: 3459321 [No Abstract] [Full Text] [Related]
36. Beneficial response to pituitary ablation following aminoglutethimide. Bundred NJ; Eremin O; Stewart HJ; Dale BA; Forrest AP Br J Surg; 1986 May; 73(5):388-9. PubMed ID: 3708294 [TBL] [Abstract][Full Text] [Related]
37. [Advanced breast cancer treated with aminoglutethimide]. Huang HY; Fei LM; Liu WH Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):178-81. PubMed ID: 3094873 [No Abstract] [Full Text] [Related]
38. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer]. Schmidt UM; Brockmann B; Geschke E Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564 [TBL] [Abstract][Full Text] [Related]
39. Treatment of metastatic breast cancer with aminoglutethimide. Asbury RF; Bakemeier RF; Fölsch E; McCune CS; Savlov E; Bennett JM Cancer; 1981 Apr; 47(8):1954-8. PubMed ID: 7226090 [TBL] [Abstract][Full Text] [Related]
40. Aminoglutethimide-induced leukopenia: a case report and review of the literature. Gez E; Sulkes A Oncology; 1984; 41(6):399-402. PubMed ID: 6504495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]